Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Thrombosis
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Thrombosis
    Risk of Deep Vein Thrombosis Following a Single Negative Whole-Leg Compression Ultrasound: A Systematic Review and Meta-analysis - (JAMA)
    Findings Suggest Single Ultrasound Sufficient for Detecting DVT in Some Patients - (DGNews)
    Low-Molecular-Weight Heparin Reduces Risk of Venous Clots in Patients With Pancreatic Cancer: Presented at ASH - (DGDispatch)
    Once-Daily Enoxaparin Feasible in Some Children at Risk of Venous Thromboembolism: Presented at ASH - (DGDispatch)
    Updated Guidelines for the Management of Antithrombotic Agents for Endoscopic Procedures - (DGNews)

    News archive

     Recent webcasts/CME - Thrombosis
    • Managing Treatment- and Disease-Related Complications in Multiple Myeloma
    • Thrombosis in Multiple Myeloma: Choice of Thromboprophylaxis Depends on Type of Therapy and Individual Risk of Patient
    • Peripheral Neuropathy in Multiple Myeloma: Early Recognition and Intervention Key to Minimize Long-Term Complications
    • Deep Vein Thrombosis in Focus: Expert Perspectives on Reducing the Burden of Venous Thromboembolism
      Update on DVT and PE in OB Gyn/Ortho Patients

      Webcasts/CME archive

       Recent cases - Thrombosis
        Unusual Right Ventricular Thrombus in a Woman with Hughes-Stovin Syndrome
        Olanzapine And Pulmonary Embolism, A Rare Association: A Case Report
        Thrombolytic Therapy in Pulmonary Embolism
        Etanercept And Venous Thromboembolism: A Case Series
        Right Atrial Thrombosis after Upgrading to a Biventricular Pacing/Defibrillation System

        Cases archive
          




        my personal edition > thrombosis > news
        divider

          E-Mail this DGNews to a colleague

        DGNews


        Herbal Supplement Ginseng Reduces Effects Of Warfarin

        CHICAGO, IL -- July 6, 2004 -- Researchers from the University of Chicago report in the July 6, 2004, issue of the Annals of Internal Medicine that ginseng, one of the best selling herbal supplements in the United States, interferes with warfarin, a drug commonly used to prevent blood clots.

        The researchers encourage anyone who takes both ginseng and warfarin, also known as Coumadin®, to notify his or her doctor and urged doctors to ask patients on warfarin if they are taking ginseng.

        "Warfarin has a narrow therapeutic index," said study author Chun-Su Yuan, M.D., Ph.D., "which means precise dosing is crucial."

        "With too small a dose," added Yuan, the Cyrus Tang Professor of Anesthesia & Critical Care and director of the Tang Center for Herbal Medicine Research at the University of Chicago, "the risk of clots increases, but too much can cause serious bleeding. So a substance, such as ginseng, that alters warfarin's effects, even slightly, can have significant consequences."

        The 'blood-thinner' warfarin, taken once a day by about 3 million people in the U.S., is used to prevent blood clots from forming or growing larger. It is often prescribed for patients with certain types of irregular heartbeat, those who have had a heart attack or undergone heart valve replacement surgery. It prevents the formation of substances that cause clots.

        Package inserts stress the importance of maintaining the proper dose. "It cannot be emphasized too strongly," notes the insert, "that treatment of each patient is a highly individualized matter. Warfarin sodium, a narrow therapeutic range drug, may be affected by factors such as other drugs and dietary Vitamin K. Dosage should be controlled by periodic determinations of prothrombin time," a measure of clotting speed.

        Yuan's team studied 20 healthy volunteer subjects for four weeks. All subjects received 5 mg a day of warfarin for three days during week one and again in week four. Beginning in week two, 12 subjects took two grams of powdered ginseng in capsules. The other eight volunteers received a placebo. The researchers monitored blood levels of warfarin and the clotting ability of the blood.

        They found that after two weeks, daily doses of ginseng significantly reduced the blood levels and the anti-clotting effects of warfarin.

        Since ginseng alone can promote bleeding and delay clot formation, the researchers were surprised to find that it reduced the anti-clotting effect of warfarin compared to those who took the placebo. They suspect that substances within ginseng may enhance the function of enzymes that break down warfarin, clearing it from the blood stream more rapidly.

        The National Institutes of Health and the Tang Center for Herbal Medicine Research funded this study. Additional authors include Gang Wei, Lucy Dey, Theodore Karrison, Linda Nahlik, Spring Maleckar, Kristen Kasza, Michael Ang-Lee and Jonathan Moss of the University of Chicago.


        SOURCE: University of Chicago Medical Center



        E-Mail this DGNews to a colleague   To print, use this version






        All contents Copyright (c) 1995-2010 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send